AVDL (Avadel Pharmaceuticals plc Ordinary Share) Stock Analysis - Analyst Ratings

Avadel Pharmaceuticals plc Ordinary Share (AVDL) is a publicly traded Healthcare sector company. As of May 20, 2026, AVDL trades at $21.39 with a market cap of $2.12B and a P/E ratio of -10.70. AVDL moved +0.00% today. Year to date, AVDL is +41.07%; over the trailing twelve months it is +140.44%. Its 52-week range spans $6.38 to $23.57. Analyst consensus is buy with an average price target of $21.25. Rallies surfaces AVDL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate AVDL?

14 analysts cover AVDL: 0 strong buy, 8 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $21.25.

AVDL Key Metrics

Key financial metrics for AVDL
MetricValue
Price$21.39
Market Cap$2.12B
P/E Ratio-10.70
EPS$-2.00
Dividend Yield0.00%
52-Week High$23.57
52-Week Low$6.38
Volume200
Avg Volume0
Revenue (TTM)$27.96M
Net Income$-160.28M
Gross Margin96.97%

AVDL Analyst Consensus

14 analysts cover AVDL: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.25.

Recent AVDL Insider Trades

  • Weiss Asset Management LP sold 11.11M (~$233.35M) on Feb 13, 2026.
  • Palczuk Linda bought 5.00K (~$39.64K) on Jan 21, 2025.
  • Thornton Peter J. bought 10.00K (~$80.45K) on Jan 13, 2025.

Common questions about AVDL

What do analysts rate AVDL?
14 analysts cover AVDL: 0 strong buy, 8 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $21.25.
Does Rallies show AVDL price targets?
Yes. Rallies tracks AVDL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is AVDL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AVDL. It does not provide personalized investment advice.
AVDL

AVDL